BUSINESS OF BIOTECH
Artikel konnten nicht hinzugefügt werden
Der Titel konnte nicht zum Warenkorb hinzugefügt werden.
Der Titel konnte nicht zum Merkzettel hinzugefügt werden.
„Von Wunschzettel entfernen“ fehlgeschlagen.
„Podcast folgen“ fehlgeschlagen
„Podcast nicht mehr folgen“ fehlgeschlagen
BUSINESS OF BIOTECH
-
Gesprochen von:
-
Von:
Über diesen Titel
In this bonus episode, which concludes the first series of the ‘Life Sci Fantastic’, Eliot steps back from examining the science of biotech to look at the business of this rapidly developing industry.
Eliot asks, what is driving those entrepreneurs to bring new treatments to patients, and what are the financial challenges in bringing these drugs to market?
Answering those questions is Bill Hicks, who has brokered deals and helped numerous companies and individuals chart the legal and financial challenges in the industry.
As co-chair of the life sciences practice at the US law firm Mintz, Bill has ridden the highs and lows of drug development, finance, stock market fluctuations, and more. In his conversation with Eliot, he reflects upon the business of bio-tech.
Host: Eliot Forster
Production team: Andy Coulson and Jane Sankey (Coulson Partners) and Richard Miron (Earshot Strategies)
With special thanks to Mintz - https://www.mintz.com
